Chris Bakal: Honoured to be named The Institute of Cancer Research Supervisor of the Year!
Neil Johnson, Founder and Chief Executive Officer at Duke Capital Limited, shared a post by
“I have known Chris Bakal and his team for almost 5 years, and his lab is the recipient of our Terry Fox Run UK fundraising. So all the money raised in the UK, stays in the UK.
In getting to know Chris and all his team, they are the most intelligent, motivated, and fun group of researchers you could ever meet – and I’m sure their team culture is because of the great leadership Chris provides. He is always out front running the Terry Fox Run as well. Keep up the good work Chris!”
Quoting Chris Bakal‘s post:
“Honoured to be named The Institute of Cancer Research Supervisor of the Year!
The award is really to the students who work so hard, take big risks, and define the culture of the Institute. All I do is try to provide a supportive environment for them.”
Source: Neil Johnson/LinkedIn and Chris Bakal/LinkedIn
Chris Bakal has led a team at The Institute of Cancer Research since 2009, focusing on the biological mechanisms that cause cells to change shape, become cancerous, and metastasize. From 2006 to 2009, he was affiliated with the Massachusetts Institute of Technology (MIT) and served as a Postdoctoral Fellow at Harvard Medical School from 2004 to 2009.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023